13 research outputs found

    A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease

    Get PDF
    Existing knowledge of genetic variants affecting risk of coronary artery disease (CAD) is largely based on genome-wide association studies (GWAS) analysis of common SNPs. Leveraging phased haplotypes from the 1000 Genomes Project, we report a GWAS meta-analysis of 185 thousand CAD cases and controls, interrogating 6.7 million common (MAF>0.05) as well as 2.7 million low frequency (0.005<MAF<0.05) variants. In addition to confirmation of most known CAD loci, we identified 10 novel loci, eight additive and two recessive, that contain candidate genes that newly implicate biological processes in vessel walls. We observed intra-locus allelic heterogeneity but little evidence of low frequency variants with larger effects and no evidence of synthetic association. Our analysis provides a comprehensive survey of the fine genetic architecture of CAD showing that genetic susceptibility to this common disease is largely determined by common SNPs of small effect siz

    A principal component meta-analysis on multiple anthropometric traits identifies novel loci for body shape

    Get PDF
    Large consortia have revealed hundreds of genetic loci associated with anthropometric traits, one trait at a time. We examined whether genetic variants affect body shape as a composite phenotype that is represented by a combination of anthropometric traits. We developed an approach that calculates averaged PCs (AvPCs) representing body shape derived from six anthropometric traits (body mass index, height, weight, waist and hip circumference, waist-to-hip ratio). The first four AvPCs explain >99% of the variability, are heritable, and associate with cardiometabolic outcomes. We performed genome-wide association analyses for each body shape composite phenotype across 65 studies and meta-analysed summary statistics. We identify six novel loci: LEMD2 and CD47 for AvPC1, RPS6KA5/C14orf159 and GANAB for AvPC3, and ARL15 and ANP32 for AvPC4. Our findings highlight the value of using multiple traits to define complex phenotypes for discovery, which are not captured by single-trait analyses, and may shed light onto new pathways

    The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale Genome-Wide Interaction Study

    Get PDF
    Genome-wide association studies (GWAS) have identified more than 100 genetic variants contributing to BMI, a measure of body size, or waist-to-hip ratio (adjusted for BMI, WHRadjBMI), a measure of body shape. Body size and shape change as people grow older and these changes differ substantially between men and women. To systematically screen for age-and/or sex-specific effects of genetic variants on BMI and WHRadjBMI, we performed meta-analyses of 114 studies (up to 320,485 individuals of European descent) with genome-wide chip and/or Metabochip data by the Genetic Investigation of Anthropometric Traits (GIANT) Consortium. Each study tested the association of up to similar to 2.8M SNPs with BMI and WHRadjBMI in four strata (men &lt;= 50y, men &gt; 50y, women &lt;= 50y, women &gt; 50y) and summary statistics were combined in stratum-specific meta-analyses. We then screened for variants that showed age-specific effects (G x AGE), sex-specific effects (G x SEX) or age-specific effects that differed between men and women (G x AGE x SEX). For BMI, we identified 15 loci (11 previously established for main effects, four novel) that showed significant (FDR&lt; 5%) age-specific effects, of which 11 had larger effects in younger (&lt; 50y) than in older adults (&gt;= 50y). No sex-dependent effects were identified for BMI. For WHRadjBMI, we identified 44 loci (27 previously established for main effects, 17 novel) with sex-specific effects, of which 28 showed larger effects in women than in men, five showed larger effects in men than in women, and 11 showed opposite effects between sexes. No age-dependent effects were identified for WHRadjBMI. This is the first genome-wide interaction meta-analysis to report convincing evidence of age-dependent genetic effects on BMI. In addition, we confirm the sex-specificity of genetic effects on WHRadjBMI. These results may providefurther insights into the biology that underlies weight change with age or the sexually dimorphism of body shape.</p

    Investigation Of Efficiency Of Polyferric Sulfate(PFS) Coagulant Compared To Poly Aluminium Choloride (PAC) in Ahvaz Water Treatment

    No full text
    Background: Coagulation process has a important place in water treatment. Currently, poly aluminum chloride is used in Kian-abad water treatment plant. The purpose of this study is to compare and investigate the efficiency of coagulants of poly ferric sulfate(PFS) against poly aluminum chloride (PAL) in removing turbidity and coliform bacteria in Ahwaz water treatment plant. Methods: This study, was performed in lab scale and using of jartest apparatus in Ahwaz water treatment. Experiments was conducted in 35NTU turbidity in Ahwaz water treatment plant. The studied parameters included concentrations of coagulants, pH, turbidity, total coliform, fecal coliform and heterotrophic bacteria. Results: The most optimal efficiency conditions of poly aluminum chloride were pH=8, rapid mixing of 120rpm and optimal dose of 5ppm which was 93.14% in pH=8 and 93.80% for optimal dose of 5ppm. The most optimal condition for poly ferric sulfate included pH=8, rapid mixing of 120 rpm and optimal dose of 8ppm. In optimal condition of performance for poly aluminum chloride, efficiency of removing total coliform, fecal coliform and heterotrophic bacteria were 90.12, 83.70, 84.08% respectively. In optimal condition of poly ferric sulfate in dose of 8ppm efficiency removing total coliform, fecal coliform, and heterotrophic bacteria were 90.48, 84.83, and 84.69. Conclusion: Finally, there was small difference between both PFS and PAC group about turbidity removal efficiency that was not significant statistically

    Active packaging films based on polyolefins modified by organic and inorganic nanoparticles

    No full text
    Nowadays, the use of polymer films for flexible packaging has gained a widespread importance because of their easy processing, good final properties, light weight and low relative cost. In order to fulfill the needs of increasingly demanding consumers respect to the quality of packaged products, additional capabilities must be incorporated into packaging. In this sense, academic and industrial efforts have focused on new technologies that provide a complementary functionality to the packaging performance. These emerging developments involve active and intelligent packaging, which can attract to consumers, improve product quality and/or balance any detrimental effect. In this context, the use of nanoparticle (NP) modified polyolefins, either in bulk (nanocomposites) or on the surface, allows the inclusion of specific functionalities. These new capabilities enable obtaining active packaging according to the requirements of the product. The aim of this chapter is to analyze the aforementioned approaches for the development of active films by incorporating antibacterial, antifungal and/or repellent functionalities. Currently, several sustainable developments of this type of active films are based on commodity thermoplastics such as poly(ethylene) and poly(propylene). These materials, modified by the incorporation of organic and inorganic NPs, are promising candidates since their final properties can be tailored for packaging application.Fil: Alonso, Yanela Natalin. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Centro CientĂ­fico TecnolĂłgico Conicet - BahĂ­a Blanca. Planta Piloto de IngenierĂ­a QuĂ­mica. Universidad Nacional del Sur. Planta Piloto de IngenierĂ­a QuĂ­mica; Argentina. Universidad Nacional del Sur. Departamento de IngenierĂ­a QuĂ­mica; ArgentinaFil: Grafia, Ana Luisa. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Centro CientĂ­fico TecnolĂłgico Conicet - BahĂ­a Blanca. Planta Piloto de IngenierĂ­a QuĂ­mica. Universidad Nacional del Sur. Planta Piloto de IngenierĂ­a QuĂ­mica; Argentina. Universidad Nacional del Sur. Departamento de IngenierĂ­a QuĂ­mica; ArgentinaFil: Castillo, Luciana Andrea. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Centro CientĂ­fico TecnolĂłgico Conicet - BahĂ­a Blanca. Planta Piloto de IngenierĂ­a QuĂ­mica. Universidad Nacional del Sur. Planta Piloto de IngenierĂ­a QuĂ­mica; Argentina. Universidad Nacional del Sur. Departamento de IngenierĂ­a QuĂ­mica; ArgentinaFil: Barbosa, Silvia Elena. Consejo Nacional de Investigaciones CientĂ­ficas y TĂ©cnicas. Centro CientĂ­fico TecnolĂłgico Conicet - BahĂ­a Blanca. Planta Piloto de IngenierĂ­a QuĂ­mica. Universidad Nacional del Sur. Planta Piloto de IngenierĂ­a QuĂ­mica; Argentina. Universidad Nacional del Sur. Departamento de IngenierĂ­a QuĂ­mica; Argentin

    A comprehensive 1000 genomes-based genome-wide association meta-analysis of coronary artery disease

    No full text

    A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease

    No full text
    Existing knowledge of genetic variants affecting risk of coronary artery disease (CAD) is largely based on genome-wide association study (GWAS) analysis of common SNPs. Leveraging phased haplotypes from the 1000 Genomes Project, we report a GWAS meta-analysis of similar to 185,000 CAD cases and controls, interrogating 6.7 million common (minor allele frequency (MAF) > 0.05) and 2.7 million low-frequency (0.005 < MAF < 0.05) variants. In addition to confirming most known CAD-associated loci, we identified ten new loci (eight additive and two recessive) that contain candidate causal genes newly implicating biological processes in vessel walls. We observed intralocus allelic heterogeneity but little evidence of low-frequency variants with larger effects and no evidence of synthetic association. Our analysis provides a comprehensive survey of the fine genetic architecture of CAD, showing that genetic susceptibility to this common disease is largely determined by common SNPs of small effect size
    corecore